title: Stroma as an Active Player in the Development of the Tumor Microenvironment.
abstract: The stroma is a considerable part of the tumor microenvironment. Because of its complexity, it can influence both cancer and immune cells in their behavior and cross-talk. Aside from soluble products released by non-cancer and cancer cells, extracellular matrix components have been increasingly recognized as more than just minor players in the constitution, development and regulation of the tumor microenvironment. The variations in the connective scaffold architecture, induced by transforming growth factor beta, lysyl oxidase and metalloproteinase activity, create different conditions of ECM density and stiffness. They exert broad effects on immune cells (e.g. physical barriers, modulation by release of stored TGF-β1), mesenchymal cells (transition to myofibroblasts), epithelial cells (epithelial-to-mesenchymal transition), cancer cells (progression to metastatic phenotype) and stem cells (activation of differentiation addressed by the microenvironment characteristics). Physiological mechanisms of the wound healing process, as well as mechanisms of fibrosis in some chronic pathologies, closely recall aspects of cancer deregulated biology. Their elucidation can provide a better understanding of tumor microenvironment immunobiology. In the following short review, we will focus on some aspects of the fibrous stroma to highlight its active participation in the tumor microenvironment constitution, tumor progression and the local immunological network.
authors.affiliation: Laboratory of Immunotherapy, Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i., Videnska 1083, 142 20, Prague 4, Czech Republic. vannucci@biomed.cas.cz.|Laboratory of Tumor Biology, Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, v.v.i., Rumburska 89, 277 21, Libechov, Czech Republic. vannucci@biomed.cas.cz.
authors.forename: L
authors.initials: L
authors.lastname: Vannucci
keywords: Fibrosis; LOX; Stiffness; TGF-β; Tumor microenvironment; Tumor stroma
references.citation: Cancer Microenviron. 2012 Dec;5(3):261-73
references.pmid: 22528876
references.citation: Cancer Sci. 2014 Mar;105(3):281-9
references.pmid: 24344732
references.citation: Arthritis Rheum. 2012 Aug;64(8):2734-45
references.pmid: 22328118
references.citation: Cell. 2012 Jun 8;149(6):1192-205
references.pmid: 22682243
references.citation: Am J Respir Cell Mol Biol. 2012 Sep;47(3):340-8
references.pmid: 22461426
references.citation: Cell. 2009 Nov 25;139(5):891-906
references.pmid: 19931152
references.citation: Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H2113-27
references.pmid: 18849330
references.citation: Cell Mol Life Sci. 2013 Dec;70(23):4431-48
references.pmid: 23649148
references.citation: Immunity. 2013 Dec 12;39(6):1003-18
references.pmid: 24332029
references.citation: Nat Immunol. 2013 Oct;14(10):986-95
references.pmid: 24048120
references.citation: ScientificWorldJournal. 2011;11:2391-402
references.pmid: 22194670
references.citation: J Pathol. 2013 Jan;229(2):176-85
references.pmid: 23096265
references.citation: Exp Cell Res. 2005 Sep 10;309(1):48-55
references.pmid: 15992798
references.citation: Cancer Res. 2013 Sep 1;73(17):5336-46
references.pmid: 23856251
references.citation: Am J Pathol. 2013 Apr;182(4):1055-64
references.pmid: 23438473
references.citation: Semin Cancer Biol. 2014 Apr;25:15-22
references.pmid: 24412104
references.citation: Biochim Biophys Acta. 2014 Apr;1845(2):182-201
references.pmid: 24440852
references.citation: J Bone Miner Res. 2011 Apr;26(4):730-8
references.pmid: 20939067
references.citation: J Cell Physiol. 2013 Aug;228(8):1651-7
references.pmid: 23460038
references.citation: Virchows Arch. 2009 Jul;455(1):67-75
references.pmid: 19543744
references.citation: J Biochem. 2012 Oct;152(4):321-9
references.pmid: 22923731
references.citation: Immunobiology. 2013 Nov;218(11):1370-5
references.pmid: 23932437
references.citation: N Engl J Med. 1986 Dec 25;315(26):1650-9
references.pmid: 3537791
references.citation: J Cell Sci. 2014 Mar 1;127(Pt 5):1079-91
references.pmid: 24424023
references.citation: Clin Sci (Lond). 2014 Mar;126(5):329-37
references.pmid: 24219159
references.citation: J Leukoc Biol. 2008 May;83(5):1136-44
references.pmid: 18285406
references.citation: Mol Biol Rep. 2011 Jan;38(1):145-9
references.pmid: 20306300
references.citation: J Immunol. 2007 Mar 1;178(5):2883-92
references.pmid: 17312132
references.citation: Bioinformation. 2011;7(7):339-46
references.pmid: 22355234
references.citation: J Tissue Viability. 2011 Nov;20(4):108-20
references.pmid: 19995679
references.citation: J Cell Biol. 1994 Jan;124(1-2):171-81
references.pmid: 8294500
references.citation: Am J Pathol. 2011 Nov;179(5):2660-73
references.pmid: 21945322
references.citation: J Transl Med. 2012 Sep 03;10:183
references.pmid: 22943793
references.citation: Carcinogenesis. 2013 Oct;34(10):2370-9
references.pmid: 23828904
references.citation: Future Oncol. 2012 Sep;8(9):1095-108
references.pmid: 23030485
references.citation: Mol Cancer Res. 2014 Mar;12(3):297-312
references.pmid: 24452359
references.citation: Cell Stem Cell. 2012 Dec 7;11(6):730-2
references.pmid: 23217416
references.citation: Mol Cancer Res. 2013 Nov;11(11):1425-36
references.pmid: 24008674
references.citation: Cancer Med. 2012 Aug;1(1):17-27
references.pmid: 23342250
references.citation: EMBO Mol Med. 2013 Feb;5(2):264-79
references.pmid: 23307470
references.citation: Pathology. 2001 Feb;33(1):85-92
references.pmid: 11280615
references.citation: Nat Cell Biol. 2013 Jun;15(6):637-46
references.pmid: 23708000
references.citation: Cancer Immunol Immunother. 2007 Nov;56(11):1687-700
references.pmid: 17571260
references.citation: Exp Cell Res. 2010 May 1;316(8):1324-31
references.pmid: 20211171
references.citation: Matrix Biol. 2013 Oct-Nov;32(7-8):424-31
references.pmid: 23648810
references.citation: Development. 2012 Apr;139(8):1522-33
references.pmid: 22434869
references.citation: Cancer Res. 2013 Sep 15;73(18):5657-68
references.pmid: 23903958
references.citation: Acta Histochem. 2007;109(4):266-72
references.pmid: 17445872
references.citation: J Cell Biol. 2007 Dec 17;179(6):1311-23
references.pmid: 18086923
references.citation: J Immunol. 2013 Apr 1;190(7):3500-9
references.pmid: 23475218
references.citation: J Innate Immun. 2012;4(5-6):463-77
references.pmid: 22507825
references.citation: Biochim Biophys Acta. 2014 Aug;1840(8):2589-98
references.pmid: 24406397
references.citation: Curr Opin Cell Biol. 2010 Oct;22(5):697-706
references.pmid: 20822891
references.citation: Immunol Invest. 2006;35(3-4):297-325
references.pmid: 16916756
references.citation: Lancet. 2001 Feb 17;357(9255):539-45
references.pmid: 11229684
references.citation: Cancer Immunol Immunother. 2004 Mar;53(3):262-74
references.pmid: 14685780
references.citation: Wound Repair Regen. 2005 Jan-Feb;13(1):7-12
references.pmid: 15659031
references.citation: J Cell Commun Signal. 2014 Jun;8(2):171-2
references.pmid: 24458847
references.citation: Biomech Model Mechanobiol. 2012 Nov;11(8):1241-9
references.pmid: 22161021
references.citation: J Cell Physiol. 2007 Apr;211(1):19-26
references.pmid: 17167774
references.citation: J Invest Dermatol. 2011 Mar;131(3):586-93
references.pmid: 21150927
references.citation: Cell Adhes Commun. 1998;6(2-3):225-36
references.pmid: 9823473
references.citation: Mol Oncol. 2014 Feb;8(1):68-82
references.pmid: 24120346
references.citation: PLoS One. 2011;6(9):e25450
references.pmid: 21980461
references.citation: Ann Rheum Dis. 2012 May;71(5):761-7
references.pmid: 22328737
references.citation: Cancer Lett. 2014 Apr 10;345(2):164-73
references.pmid: 23988267
references.citation: Curr Biol. 2011 Dec 20;21(24):2046-54
references.pmid: 22169532
references.citation: Eur J Cell Biol. 2008 Sep;87(8-9):601-15
references.pmid: 18342983
references.citation: Hum Cell. 2012 Dec;25(4):87-95
references.pmid: 23242923
references.citation: Blood. 2008 May 1;111(9):4571-9
references.pmid: 18310502
references.citation: Nat Rev Mol Cell Biol. 2002 May;3(5):349-63
references.pmid: 11988769
references.citation: J Invest Dermatol. 2009 Jul;129(7):1614-27
references.pmid: 19177135
references.citation: Cancer Metastasis Rev. 2006 Dec;25(4):677-94
references.pmid: 17160713
references.citation: Semin Immunol. 2013 Dec 15;25(6):430-8
references.pmid: 24183701
references.citation: J Cell Sci. 2001 Jan;114(Pt 1):187-197
references.pmid: 11112702
references.citation: Nature. 2013 Dec 12;504(7479):277-281
references.pmid: 24336287
references.citation: Cancer Metastasis Rev. 2006 Sep;25(3):435-57
references.pmid: 16951986
references.citation: Adv Cancer Res. 1998;75:87-134
references.pmid: 9709808
references.citation: Proc Natl Acad Sci U S A. 1988 Jul;85(13):4894-7
references.pmid: 3164478
references.citation: Nat Rev Cancer. 2013 Nov;13(11):788-99
references.pmid: 24132110
references.citation: J Am Soc Nephrol. 2013 Oct;24(10):1627-42
references.pmid: 23990681
references.citation: J Cell Physiol. 2013 Jul;228(7):1404-12
references.pmid: 23065796
references.citation: Dev Immunol. 2000;7(2-4):249-66
references.pmid: 11097216
references.citation: Cancers (Basel). 2011 Sep 28;3(4):3740-61
references.pmid: 24213109
references.citation: Cancer Metastasis Rev. 2011 Mar;30(1):13-25
references.pmid: 21271351
references.citation: Ann Dermatol. 2013 May;25(2):135-44
references.pmid: 23717002
references.citation: Cancer Biol Ther. 2006 Aug;5(8):909-11
references.pmid: 16969095